|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
RU2011133071A
(ru)
|
2009-01-06 |
2013-02-20 |
Нестек С.А. |
Переработка макронутриентов
|
|
NZ594514A
(en)
|
2009-03-05 |
2013-06-28 |
Abbott Lab |
Interleukin-17 BINDING PROTEINS
|
|
US10087408B2
(en)
|
2010-07-07 |
2018-10-02 |
The University Of British Columbia |
System and method for microfluidic cell culture
|
|
US9188593B2
(en)
|
2010-07-16 |
2015-11-17 |
The University Of British Columbia |
Methods for assaying cellular binding interactions
|
|
WO2012176779A1
(ja)
*
|
2011-06-20 |
2012-12-27 |
協和発酵キリン株式会社 |
抗erbB3抗体
|
|
CA2909952C
(en)
|
2013-04-29 |
2021-10-12 |
Teva Pharmaceuticals Australia Pty Ltd. |
Anti-cd38 antibodies and fusions to attenuated interferon alpha-2b
|
|
EP3041865A2
(en)
|
2013-09-03 |
2016-07-13 |
NovImmune S.A. |
Readily isolated bispecific binding molecules with native format having mutated constant regions
|
|
CN105218669A
(zh)
|
2014-06-10 |
2016-01-06 |
河北翰林生物科技有限公司 |
制备抗人r47h-trem2突变体的人单克隆抗体的方法
|
|
EA201790342A1
(ru)
*
|
2014-08-08 |
2017-07-31 |
ЭЛЕКТОР ЭлЭлСи |
Антитела к trem2 и способы их применения
|
|
KR20240056629A
(ko)
|
2014-09-28 |
2024-04-30 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
자극성 및 비자극성 골수성 세포의 조절
|
|
JP6996979B2
(ja)
*
|
2015-03-31 |
2022-02-04 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
三量体tnfファミリーリガンドを含む抗原結合分子
|
|
WO2017058866A1
(en)
*
|
2015-09-28 |
2017-04-06 |
Precision Immune, Inc. |
Anti-trem2 antibodies and uses thereof
|
|
JP7725185B2
(ja)
*
|
2015-10-06 |
2025-08-19 |
アレクトル エルエルシー |
抗trem2抗体及びその使用方法
|
|
WO2017147509A1
(en)
|
2016-02-25 |
2017-08-31 |
Marco Colonna |
Compositions comprising trem2 and methods of use thereof
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
JP2019531332A
(ja)
|
2016-07-22 |
2019-10-31 |
ドイチェス ツェントルム フュール ノイロデゲネラティフェ アークランクンゲン エー.ファウ.(デーツェットエンエー) |
Trem2切断モジュレーター及びその使用
|
|
CN118271442A
(zh)
|
2016-12-23 |
2024-07-02 |
蓝鳍生物医药公司 |
抗sez6l2抗体和抗体药物缀合物
|
|
US20190367623A1
(en)
|
2017-01-17 |
2019-12-05 |
Yeda Research And Development Co. Ltd. |
Methods of treating neurodegenerative diseases by inducing disease-associated microglia (dam) cells
|
|
CA3053379A1
(en)
|
2017-02-17 |
2018-08-23 |
Denali Therapeutics Inc. |
Anti-tau antibodies and methods of use thereof
|
|
CA3053381A1
(en)
|
2017-02-17 |
2018-08-23 |
Denali Therapeutics Inc. |
Engineered polypeptides
|
|
RS63818B1
(sr)
|
2017-02-17 |
2023-01-31 |
Denali Therapeutics Inc |
Konstruisani polipeptidi za vezivanje za receptor transferina
|
|
JOP20190248A1
(ar)
*
|
2017-04-21 |
2019-10-20 |
Amgen Inc |
بروتينات ربط مولد ضد trem2 واستخداماته
|
|
BR112020001060A2
(pt)
|
2017-07-27 |
2020-07-14 |
Novartis Ag |
variantes de trem2 resistentes a shedase
|
|
HUE062436T2
(hu)
*
|
2017-08-03 |
2023-11-28 |
Alector Llc |
Anti-trem2 antitestek és alkalmazási módszereik
|
|
WO2019032955A1
(en)
|
2017-08-10 |
2019-02-14 |
Denali Therapeutics Inc. |
MODIFIED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES
|
|
WO2019055841A1
(en)
|
2017-09-14 |
2019-03-21 |
Denali Therapeutics Inc. |
ANTI-TREM2 ANTIBODIES AND METHODS OF USE
|
|
BR112020005271A2
(pt)
|
2017-10-02 |
2020-09-15 |
Denali Therapeutics Inc. |
proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica
|
|
WO2019079529A1
(en)
|
2017-10-17 |
2019-04-25 |
The Translational Genomics Research Institute |
TREM2 AGONISTS FOR STIMULATING MICROGLIA AND IDENTIFICATION METHODS
|
|
WO2019094608A1
(en)
|
2017-11-08 |
2019-05-16 |
Denali Therapeutics Inc. |
Anti-bace1 antibodies and methods of use thereof
|
|
MX2020006213A
(es)
|
2017-12-12 |
2020-09-14 |
Pionyr Immunotherapeutics Inc |
Anticuerpos anti-trem2 y metodos relacionados.
|
|
BR112020013921A2
(pt)
|
2018-01-10 |
2020-12-01 |
Denali Therapeutics Inc. |
polipeptídeos de ligação ao receptor de transferrina e usos destes
|
|
WO2019246071A1
(en)
|
2018-06-18 |
2019-12-26 |
Denali Therapeutics Inc. |
Fusion proteins comprising progranulin
|
|
GB201811404D0
(en)
|
2018-07-12 |
2018-08-29 |
F Star Beta Ltd |
Anti-CD137 Antibodies
|
|
CA3109763A1
(en)
|
2018-08-16 |
2020-02-20 |
Denali Therapeutics Inc. |
Engineered bispecific proteins
|
|
EP3840781A1
(en)
|
2018-08-22 |
2021-06-30 |
Denali Therapeutics Inc. |
Anti-her2 polypeptides and methods of use thereof
|
|
SG11202102162RA
(en)
|
2018-09-11 |
2021-04-29 |
Univ Washington |
Anti-trem-2 agonist antibodies
|
|
UY38407A
(es)
|
2018-10-15 |
2020-05-29 |
Novartis Ag |
Anticuerpos estabilizadores de trem2
|
|
KR102156165B1
(ko)
|
2018-10-29 |
2020-09-15 |
재단법인대구경북과학기술원 |
인간 trem2 세포막 단백질에 대한 단일클론항체, 이를 생산하는 하이브리도마 세포주 및 이의 용도
|
|
CN113302206A
(zh)
|
2018-11-26 |
2021-08-24 |
戴纳立制药公司 |
治疗脂质代谢失调的方法
|
|
EP3894864A2
(en)
|
2018-12-10 |
2021-10-20 |
Denali Therapeutics Inc. |
Lysosomal storage disorder biomarkers and methods of use thereof
|
|
CA3122725A1
(en)
|
2018-12-10 |
2020-06-18 |
Mor Research Applications |
Trem2 antibodies and uses thereof
|
|
CA3120875A1
(en)
|
2018-12-11 |
2020-06-18 |
Pionyr Immunotherapeutics, Inc. |
Methods of using anti-trem2 antibodies
|
|
JP7543290B2
(ja)
|
2019-02-20 |
2024-09-02 |
デナリ セラピューティクス インコーポレイテッド |
抗trem2抗体及びその使用方法
|
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
|
AU2020252554B2
(en)
|
2019-04-03 |
2026-05-28 |
Denali Therapeutics Inc. |
Formulations of protein molecules comprising iduronate 2-sulfatase
|
|
BR112022012230A2
(pt)
|
2019-12-23 |
2022-08-30 |
Denali Therapeutics Inc |
Variantes de progranulina
|
|
WO2021146256A1
(en)
|
2020-01-13 |
2021-07-22 |
Denali Therapeutics Inc. |
Anti-trem2 antibodies and methods of use thereof
|
|
US11124567B2
(en)
|
2020-01-13 |
2021-09-21 |
Denali Therapeutics Inc. |
Anti-TREM2 antibodies and methods of use thereof
|
|
WO2021158986A1
(en)
|
2020-02-07 |
2021-08-12 |
Denali Therapeutics Inc. |
Methods for the treatment of hunter syndrome
|
|
CA3170338A1
(en)
|
2020-02-19 |
2021-08-26 |
Denali Therapeutics Inc. |
Engineered anti-her2 bispecific proteins
|
|
CR20230178A
(es)
|
2020-10-14 |
2023-07-26 |
Denali Therapeutics Inc |
Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas
|